ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 130 filers reported holding ASCENDIS PHARMA A/S in Q3 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $90,404,665 | -2.6% | 662,888 | +7.9% | 6.62% | +7.0% |
| Q1 2024 | $92,834,555 | +36.5% | 614,107 | +13.7% | 6.18% | +26.4% |
| Q4 2023 | $68,006,451 | +18.2% | 539,948 | -12.1% | 4.89% | +8.5% |
| Q3 2023 | $57,552,830 | -2.0% | 614,618 | -6.6% | 4.51% | +6.3% |
| Q2 2023 | $58,713,380 | -23.3% | 657,853 | -7.9% | 4.24% | -26.5% |
| Q1 2023 | $76,551,435 | -12.3% | 713,966 | -0.1% | 5.77% | -17.6% |
| Q4 2022 | $87,257,122 | -11.0% | 714,461 | -24.8% | 7.01% | +1.0% |
| Q3 2022 | $98,088,000 | -4.9% | 949,915 | -14.4% | 6.94% | +21.0% |
| Q2 2022 | $103,155,000 | -27.0% | 1,109,670 | -7.8% | 5.74% | +18.8% |
| Q1 2022 | $141,300,000 | -19.9% | 1,203,990 | -8.2% | 4.83% | +3.1% |
| Q4 2021 | $176,492,000 | -19.7% | 1,311,915 | -4.9% | 4.68% | -7.1% |
| Q3 2021 | $219,781,000 | +48.8% | 1,378,887 | +22.8% | 5.04% | +53.4% |
| Q2 2021 | $147,687,000 | +18.0% | 1,122,671 | +15.6% | 3.29% | -0.4% |
| Q1 2021 | $125,156,000 | +7.0% | 971,105 | +38.4% | 3.30% | -8.2% |
| Q4 2020 | $117,012,000 | +38.6% | 701,594 | +28.3% | 3.59% | -8.0% |
| Q3 2020 | $84,416,000 | +26.2% | 547,022 | +21.0% | 3.90% | -5.8% |
| Q2 2020 | $66,866,000 | +69.0% | 452,104 | +28.7% | 4.14% | -7.4% |
| Q1 2020 | $39,570,000 | +13.3% | 351,388 | +40.0% | 4.47% | -0.3% |
| Q4 2019 | $34,915,000 | +171.1% | 250,972 | +87.7% | 4.48% | +31.1% |
| Q3 2019 | $12,877,000 | +1.0% | 133,689 | +20.7% | 3.42% | -15.2% |
| Q2 2019 | $12,752,000 | +20.3% | 110,740 | +23.0% | 4.03% | -1.8% |
| Q1 2019 | $10,601,000 | +292.9% | 90,065 | +109.1% | 4.10% | +102.9% |
| Q4 2018 | $2,698,000 | – | 43,065 | – | 2.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,240,536 | $300,484,000 | 16.06% |
| Sofinnova Investments, Inc. | 2,479,514 | $175,698,000 | 15.66% |
| Vivo Capital, LLC | 2,166,832 | $153,542,000 | 15.48% |
| VHCP Management II, LLC | 504,210 | $35,728,000 | 9.54% |
| EcoR1 Capital, LLC | 1,087,257 | $77,043,000 | 6.94% |
| Avoro Capital Advisors LLC | 1,963,336 | $139,122,000 | 6.39% |
| Foresite Capital Management IV, LLC | 245,424 | $17,391,000 | 5.70% |
| Eventide Asset Management | 1,544,900 | $109,472,000 | 4.02% |
| Orbimed Advisors | 4,155,891 | $294,486,000 | 3.55% |
| Ghost Tree Capital, LLC | 225,000 | $15,944,000 | 3.39% |